RDRima M. Dafer

Rima M. Dafer

*This is an algorithmically generated author record based on publicly available information.

Rima M. Dafer has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanical thrombectomy and decompressive hemicraniectomy trends for acute ischemic stroke: A nationwide analysis

    by Lucinda T. Chiu, Ethan Ritz, Krishna Joshi, Nathan J. Pertsch, Elsa Olson, Zain Ashary, Rima Dafer, James Conners, Stephan A. Munich

  • Language Discordance in Telestroke Thrombolysis Recommendations

    by Alejandro Vargas, Laurel Cherian, James J. Conners, Rima M. Dafer, Sarah Y. Song, Nicholas D. Osteraas

    Introduction: It is unknown if language discordance between patient and provider during telestroke evaluations involves differences in stroke metrics, severity, or outcomes when compared to language concordant (LC) situations. We sought to evaluate differences in patient demographics, stroke severity, and treatment times for patients where intravenous thrombolysis was recommended for suspected acute ischemic stroke (AIS) between LC and language discordant (LD) patient and physician encounters. Methods: This cross-sectional study was a retrospective analysis of prospectively collected data after recommendation to administer intravenous tissue plasminogen activator (IV tPA) between July 2017 and July 2020. Consecutive patients where thrombolysis was recommended for suspected AIS were included, from a single academic center telestroke network with multiple spoke sites. Primary language, time of telestroke evaluation, time to IV tPA recommendation, initial National Institutes of Health Stroke Scale, and demographic information were abstracted. Data were dichotomized into LC for English-speaking patients and providers vs. LD for non-English-speaking patients with English-speaking providers. Results: A total of 705 LC patient encounters and 42 LD patient encounters were identified. LD patients were older (70 years versus 65 years, p = 0.04) and had a trend to higher stroke severity (median NIHSS 7 versus 6, p = 0.09) than LC patients. Limited outcome data were available only for patients transferred to the comprehensive stroke center hub for a higher level of care or consideration for endovascular thrombectomy, but no significant outcome findings were seen. Conclusions: LD patients who are evaluated via telestroke were significantly older and had a trend to higher stroke severity as measured by initial NIHSS. Further dedicated data collection on the effects of language in acute stroke metrics in larger cohorts is necessary.

  • Open Access

    Migraine Genetic Susceptibility Does Not Strongly Influence Migraine Characteristics and Outcomes in a Treated, Real-World, Community Cohort

    by Bruce A. Chase, Roberta Frigerio, Susan Rubin, Irene Semenov, Steven Meyers, Angela Mark, Thomas Freedom, Revital Marcus, Rima Dafer, Jun Wei, et al.

    Background/Objectives: Migraine is a common neurological disorder with highly variable characteristics. While genome-wide association studies have identified genetic risk factors that implicate underlying pathways, the influence of genetic susceptibility on disease characteristics or treatment response is incompletely understood. We examined the relationships between a previously developed standardized integrative migraine polygenic genetic risk score (PRS) and migraine characteristics in a real-world, treated patient cohort. Methods: This retrospective cohort study used covariate-adjusted regression to comprehensively evaluate associations between the PRS and clinical characteristics in 1653 treated migraine cases with European ancestry at baseline and, in 800 cases, after one year. Cases were deeply phenotyped by neurologists during extensive interviews, using structured clinical documentation tools to record ~200 discrete data elements. Results: In treated patients, higher standardized PRS showed associations with two common migraine symptoms: photophobia (odds ratio [confidence interval]: 1.33 [1.13–1.56], p = 0.001) and stabbing pain (1.21 [1.08–1.36], p = 0.001]; both retained significance at Q = 0.05. Associations with phonophobia, nausea, emesis, and unilateral headache had similar effect sizes but did not survive correction for multiple tests. In this population, the PRS was not associated with other symptoms of migraine attacks, objective measures of migraine disability, frequency, severity, average duration, time-to-peak intensity of migraine attacks, chronification, emergency department visits, triptan responsiveness, or changes at follow-up. Conclusions: In treated patients, genetic risk was associated with common migraine symptoms but not with the severity of migraine characteristics or treatment outcomes. This suggests that in treated patients, other genetic and non-genetic factors influence migraine symptom severity and disease course more strongly than genetic susceptibility.


  • Open Access

    An Integrative Migraine Polygenic Risk Score Is Associated with Age at Onset But Not Chronification

    by Bruce A. Chase, Roberta Frigerio, Susan Rubin, Tiffani Franada, Irene Semenov, Steven Meyers, Stuart Bergman-Bock, Angela Mark, Thomas Freedom, Revital Marcus, et al.

    Background/Objective: Genome-wide association studies (GWASs) demonstrate a complex genetic landscape for migraine risk. Migraine polygenic risk scores (PRSs) developed from GWAS data may have utility for predicting disease course. We analyzed the strength of association between an integrative migraine PRS and age at onset and chronification. Methods: In this retrospective clinical/genetic case–control study, PGS004799 was calculated for adults with European ancestry from two real-world community cohorts. In the DodoNA cohort, 1653 treated, deeply phenotyped migraine cases, diagnosed using International Classification of Headache Disorders 3rd edition criteria, were followed for a mean (range) of 2.3 (1–10) years and compared to 3460 controls (without migraine diagnosis). In the GHI cohort, 2443 cases were identified using the first migraine ICD code as a proxy for migraine onset and compared to 8576 controls (without migraine ICD codes). PRS associations with age at onset (DodoNA) or first migraine ICD code (GHI) and chronification (DodoNA) were evaluated. Results: In both cohorts, PRS was higher in cases (DodoNA mean (range) cases: 0.82 (0.07–1.76), controls: 0.78 (0.04–1.56); t (5111) = −6.1, p = 1.4 × 10−9, GHI: cases: 0.79 (0.003–1.68), controls: 0.75 (−0.06–1.53); t (11,017) = −7.69, p = 1.6 × 10−14), and a higher PRS was associated with earlier onset in females (HR [95% CI] DodoNA: 2.1 [1.6–2.6, p < 0.001; GHI: 1.8 [1.4–2.1], p < 0.001) and in males (DodoNA: 2.5 [1.3–4.7], p = 0.005; GHI: 1.6 [1.1–2.6], p = 0.027). PRS was not different in cases with or without chronification (t (1651) = −1.67, p = 0.094) and was not associated with earlier chronification (1.2 [0.8–1.6], p = 0.424). Conclusions: Higher genetic risk was associated with earlier onset and increased risk of migraine well into adulthood, but not with chronification. This suggests that the PRS quantifies genetic susceptibility that is distinct from factors influencing disease course.


  • Non-atherosclerotic Cerebral Vasculopathies

    by Rima M. Dafer, Nicholas D. Osteraas

  • Advances in Management of the Stroke Etiology One-Percenters

    by Nicholas D. Osteraas, Rima M. Dafer

    Purpose of Review Uncommon causes of stroke merit specific attention; when clinicians have less common etiologies of stoke in mind, the diagnosis may come more easily. This is key, as optimal management will in many cases differs significantly from “standard” care. Recent Findings Randomized controlled trials (RCT) on the best medical therapy in the treatment of cervical artery dissection (CeAD) have demonstrated low rates of ischemia with both antiplatelet and vitamin K antagonism. RCT evidence supports the use of anticoagulation with vitamin K antagonism in “high-risk” patients with antiphospholipid antibody syndrome (APLAS), and there is new evidence supporting the utilization of direct oral anticoagulation in malignancy-associated thrombosis. Migraine with aura has been more conclusively linked not only with increased risk of ischemic and hemorrhagic stroke, but also with cardiovascular mortality. Recent literature has surprisingly not provided support the utilization of l-arginine in the treatment of patients with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS); however, there is evidence at this time that support use of enzyme replacement in patients with Fabry disease. Additional triggers for reversible cerebral vasoconstriction syndrome (RCVS) have been identified, such as capsaicin. Imaging of cerebral blood vessel walls utilizing contrast-enhanced MRA is an emerging modality that may ultimately prove to be very useful in the evaluation of patients with uncommon causes of stroke. A plethora of associations between cerebrovascular disease and COVID-19 have been described. Where pertinent, authors provide additional tips and guidance. Summary Less commonly encountered conditions with updates in diagnosis, and management along with clinical tips are reviewed.


  • Open Access

    Leptomeningeal Carcinomatosis Mimicking Reversible Cerebral Vasoconstriction Syndrome

    by Parneet Grewal, Julianne P. Hall, Sumeet G. Dua, Lauren Koffman, Rima M. Dafer

    Leptomeningeal carcinomatosis is the result of metastatic infiltration of the leptomeninges by malignant cells originating from an extra-meningeal primary tumor site. We describe a patient with active breast cancer who presented with thunderclap headaches (THs) and imaging showing multi-segment irregular arterial narrowing of intracranial vasculature. A 58-year-old Caucasian woman with active stage IV estrogen receptor-positive breast adenocarcinoma and migraine presented with THs. Computed tomography and brain magnetic resonance imaging (MRI) without contrast were unremarkable. Over a period of one week, she had recurrent THs. Interval vessel imaging showed multi-segment irregular arterial narrowing. Treatment with verapamil was initiated for suspected reversible cerebral vasoconstriction syndrome (RCVS). She subsequently had two discrete episodes of confusion with aphasia and left upper extremity numbness. Repeat gadolinium-enhanced MRI showed nodular leptomeningeal enhancement. Lumbar puncture revealed malignant cells in the cerebrospinal fluid consistent with leptomeningeal carcinomatosis. She subsequently underwent whole brain radiation treatment and intrathecal chemotherapy and had no further episodes of TH. Our case emphasizes the importance of considering leptomeningeal carcinomatosis in the differential diagnosis of THs and reversible cerebral vasculopathy, especially in patients with known underlying active cancer. The illustration also proves the importance of a complete work-up in patients with known malignancy in the setting of suspected RCVS.

  • Acute Large Vessel Ischemic Stroke in Patients With COVID-19–Related Multisystem Inflammatory Syndrome

    by Jaimie Chang, Zachary Bulwa, Hannah Breit, Laurel J. Cherian, James J. Conners, Sarah Y. Song, Rima M. Dafer